Sign Up to like & get
recommendations!
1
Published in 2018 at "RMD Open"
DOI: 10.1136/rmdopen-2018-000749
Abstract: Objective To evaluate the magnitude of response to secukinumab treatment over 3 years in patients with ankylosing spondylitis (AS) grouped by baseline C-reactive protein (CRP) levels in a pooled study of two pivotal phase III…
read more here.
Keywords:
baseline reactive;
response;
ankylosing spondylitis;
response secukinumab ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002303
Abstract: Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations. Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and axial…
read more here.
Keywords:
response;
secukinumab patients;
response secukinumab;
axial manifestations ... See more keywords